Avantages
Conceptually a great step forward using technology that is mostly outdated. Possibilities are there, but the proper people to make it happen are not.
Inconvénients
Upper management essentially were unsuccessful at another radiation therapy company. They have now been brought aboard at Viewray, and are applying the same systemic problematic strategies. 1. The R & D, QA/RA and FSE teams are very strong, and essentially are what keep Viewray going. Other departments (i.e. NPI, MFG and OPS) demonstrate limited medical device experience and/or relevant technology knowledge. 2. All decisions are reactionary in nature and implemented through brute force and/or intimidation. 3. Current systems in used require full-time on-site FSE teams.